Search…

Lates News

20/09/2025

On September 19th local time, MapLight Therapeutics, a clinical-stage biopharmaceutical company supported by Novo Nordisk, filed for a US IPO. The documents show that the company's lead candidate products include two drugs for treating schizophrenia and psychosis associated with Alzheimer's disease (ADP).

Latest

3 m ago

Liaoning's "1+N" policy system strongly supports the development of the private economy.

10 m ago

The annual output value of Guizhou wind power equipment manufacturing industry exceeds 15 billion yuan.

10 m ago

The National Healthcare Security Administration releases the results of the expert evaluation phase of the declaration of drugs that have passed the formal review of the adjustment of the 2025 national basic medical insurance directory and the commercial insurance innovative drug directory.

13 m ago

The State Medical Insurance Administration issued a public announcement regarding the expert review phase of the declaration medication for the formative examination of the adjustment of the National Basic Medical Insurance Catalog and the Commercial Health Insurance Innovative Drug Catalog for the year 2025.

16 m ago

Yiwu brand collection stores can be found all over the world.

See all latest